The potential of targeting ribosome biogenesis in high-grade serous ovarian cancer

S Yan; D Frank; J Son; KM Hannan; RD Hannan; KT Chan; RB Pearson; E Sanij

Journal article

The potential of targeting ribosome biogenesis in high-grade serous ovarian cancer

S Yan, D Frank, J Son, KM Hannan, RD Hannan, KT Chan, RB Pearson, E Sanij

International Journal of Molecular Sciences | MDPI AG | Published : 2017

DOI: 10.3390/ijms18010210

Download PDF

Abstract

Overall survival for patients with ovarian cancer (OC) has shown little improvement for decades meaning new therapeutic options are critical. OC comprises multiple histological subtypes, of which the most common and aggressive subtype is high-grade serous ovarian cancer (HGSOC). HGSOC is characterized by genomic structural variations with relatively few recurrent somatic mutations or dominantly acting oncogenes that can be targeted for the development of novel therapies. However, deregulation of pathways controlling homologous recombination (HR) and ribosome biogenesis has been observed in a high proportion of HGSOC, raising the possibility that targeting these basic cellular processes may p..

View full abstract

University of Melbourne Researchers

Richard Pearson Author

Elaine Sanij Author

Related Projects (10)

Immune regulation, effector function and therapy

The immune system plays an important role in protecting the host from viral and bacterial infections, and inhibits cancer onset and progress..

Novel regulation of rDNA transcription by mTOR/S6K signalling

Increased cellular growth requires a number of important processes to occur, the most fundamental of which is protein synthesis. Successful ..

AKT regulation of growth and proliferation

Ribosome synthesis and function is critical for normal cell growth and division and hence this process is exquisitely regulated. Conversely,..

Regulation of ribosomal gene transcription by c-MYC during differentiation and lymphomagenesis.

A fundamental question in medical biology revolves around how cells respond to the demands to grow and produce proteins, particularly in the..

"Deregulation of ribosome signalling, synthesis and function during malignant transformation."

A major feature of tumour progression is accelerated cell growth and protein synthesis. Moreover, increased synthesis of ribosomes (the prot..

Anti-cancer activities of HDAC inhibitors

HDAC inhibitors (HDACi) are new chemotherapeutic drugs that kill tumors cells through a cell suicide process called apoptosis. We have now e..

New therapies for MYC-associated cancers

This proposal will evaluate a new strategy for treating cancers associated with the cancer causing gene MYC. Globally there are more than 1 ..

ONCOGENIC SIGNALING AND CANCER THERAPY

Central to improving the management of patients with cancer is an understanding of the molecular drivers of cancer. Based on our fundamental..

Targetting deregulated signalling pathways in high-grade serous ovarian cancer: Defining therapeutic response and mechanisms of resistance

Ovarian cancer is the major cause of death from gynaecological cancer. Most patients present with advanced disease and die of their cancer. ..

UTILISING PI3K/AKT-DEPENDENT SENESCENCE TO TREAT CANCER

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, project grants (#1043884, 251608, 566702, 166908, 251688, 509087, 400116, 400120, 566876) and a NHMRC Program Grant (#1053792). Cancer Council Victoria research grant (#1065118). Ross D. Hannan and Richard B. Pearson were funded by NHMRC Fellowships.